{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:22:16Z","timestamp":1725481336247},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/bf02760701","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T11:07:20Z","timestamp":1200913640000},"page":"149-157","source":"Crossref","is-referenced-by-count":12,"title":["Short stature and growth hormone"],"prefix":"10.1007","volume":"72","author":[{"given":"Manmohan","family":"Kamboj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02760701_CR1","first-page":"1","volume-title":"Pediatric Endocrinology","author":"F Lifshitz","year":"2003","unstructured":"Lifshitz F, Botero D. Worrisome Growth in Pediatric. In Lifshitz F, ed.Pediatric Endocrinology; 4th edn. New York, U.S.A. Marcel Dekker 2003; 1\u201346.","edition":"4th edn"},{"key":"BF02760701_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standard for height, weight, height velocity, weight velocity and stages of puberty.Arch Dis Child 1976; 51: 170\u2013171.","journal-title":"Arch Dis Child"},{"key":"BF02760701_CR3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/adc.50.1.14","volume":"50","author":"JM Tanner","year":"1975","unstructured":"Tanner JM, Whitehouse RH, Marshall WA, Carter BS. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16, with allowance for midparent height.Arch Dis Child 1975; 50: 14\u201326.","journal-title":"Arch Dis Child"},{"key":"BF02760701_CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","volume":"40","author":"N Bayley","year":"1952","unstructured":"Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standard.J Pediatr 1952; 40: 423\u2013441.","journal-title":"J Pediatr"},{"key":"BF02760701_CR5","volume-title":"Assessment of skeletal maturity and prediction of adult height (TW2 Method)","author":"JM Tanner","year":"1983","unstructured":"Tanner JM, Whitehouse RH, Cameron Net al. Assessment of skeletal maturity and prediction of adult height (TW2 Method). London: Academic Press, 1983."},{"key":"BF02760701_CR6","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd edn. Stanford, CA, Stanford University Press, U.S.A. 1959.","edition":"2nd edn"},{"key":"BF02760701_CR7","volume-title":"Pediatric Endocrinology","author":"RG Rosenfeld","year":"2002","unstructured":"Rosenfeld RG, Cohen P. Disorders of GH\/insulin-like growth factor secretion and action. In Sperling MA, ed.Pediatric Endocrinology; 2nd edn. Saunders, U.S.A. 2002.","edition":"2nd edn"},{"issue":"5","key":"BF02760701_CR8","first-page":"1532","volume":"80","author":"RG Rosenfeld","year":"2005","unstructured":"Rosenfeld RG, Albertsson-Wikland K, Cassorla Fet al. Diagnostic controversy: The diagnosis of childhood GH deficiency revisited.J Clin Endocrinol Metab 1995; 80(5): 1532\u20131540.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"BF02760701_CR9","first-page":"3990","volume":"85","author":"GH Research Society","year":"2000","unstructured":"GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone deficiency in childhood and adolescence: summary statement of the GH Research Society.J Clin Endocrinol Metab 2000; 85(11): 3990\u20133993.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BF02760701_CR10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/jcem.84.4.5614","volume":"84","author":"M Maghnie","year":"1999","unstructured":"Maghnie M, Strigazzi C, Tinelli Cet al. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.J Clin Endocrinol Metab 1999; 84(4): 1324\u20131328.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BF02760701_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","volume":"143","author":"TA Wilson","year":"2003","unstructured":"Wilson TA, Rose SR, Cohen Pet al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.J Pediatr 2003; 143(4): 415\u2013421.","journal-title":"J Pediatr"},{"issue":"9","key":"BF02760701_CR12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3928\/0090-4481-20000901-09","volume":"29","author":"MH MacGillivray","year":"2000","unstructured":"MacGillivray MH. The basics for the diagnosis and management of short stature: a pediatric endocrinologist's approach.Pediatr Annals 2000; 29(9): 570\u2013575.","journal-title":"Pediatr Annals"},{"issue":"1","key":"BF02760701_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jcem.87.1.8150","volume":"87","author":"P Cohen","year":"2002","unstructured":"Cohen P, Bright GM, Rogol ADet al. Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.J Clin Endocrinol Metab 2002; 87(1): 90\u201398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"BF02760701_CR14","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1210\/jcem.86.10.7932","volume":"86","author":"EO Reiter","year":"2001","unstructured":"Reiter EO, Attie KM, Moshang T Jret al. A multicenter study of the efficacy and safety of sustained release GH in the treatment of na\u00efve pediatric patients with GH deficiency.J Clin Endocrinol Metab 2001; 86(10): 4700\u20134706.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"BF02760701_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1542\/peds.111.6.1253","volume":"111","author":"PA Lee","year":"2003","unstructured":"Lee PA, Chernausek SD, Hokken-Koelega AC, Czernichow P. International Small for Gestational Age Advisory Board. International small for gestational age advisor board consensus development conference statement: Management of short children born small for gestational age, April 24\u2013October 1, 2001.Pediatrics 2003; 111(6): 1253\u20131261.","journal-title":"Pediatrics"},{"issue":"23","key":"BF02760701_CR16","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa010107","volume":"349","author":"MJ Abuzzahab","year":"2003","unstructured":"Abuzzahab MJ, Schneider A, Goddard Aet al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.N Engl J Med 2003; 349(23): 2211\u20132212.","journal-title":"N Engl J Med"},{"key":"BF02760701_CR17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jcem.84.5.5697","volume":"845","author":"F Zegher de","year":"1999","unstructured":"de Zegher F, Du Caju MV, Heinrichs Cet al. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.J Clin Endocrinol Metab 1999; 845: 1558\u20131561.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"BF02760701_CR18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1651-2227.1998.tb01434.x","volume":"87","author":"M Boguszewski","year":"1998","unstructured":"Boguszewski M, Albertsson-Wikland K, Aronsson Set al. Growth hormone treatment of short children born small-for-gestational-age: The Nordic Multicentre Trial.Acta Paediatr 1998; 87(3): 257\u2013263.","journal-title":"Acta Paediatr"},{"issue":"1","key":"BF02760701_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","volume":"88","author":"MB Ranke","year":"2003","unstructured":"Ranke MB, Lindberg A, Cowell CTet al. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).J Clin Endocrinol Metab 2003; 88(1): 125\u2013131.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"BF02760701_CR20","first-page":"2969","volume":"86","author":"GA Kamp","year":"2001","unstructured":"Kamp GA, Mul D, Waelkens JJet al. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.J Clin Endocrinol Metab 2001; 86(7): 2969\u20132975.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BF02760701_CR21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2002-021123","volume":"88","author":"JC Carel","year":"2003","unstructured":"Carel JC, Chatelain P, Rochiccioli P, Chaussain JL. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study.Endocrinol Metab 2003; 88(4): 1587\u20131593.","journal-title":"Endocrinol Metab"},{"issue":"6","key":"BF02760701_CR22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2003.01905.x","volume":"59","author":"NJ Arends","year":"2003","unstructured":"Arends NJ, Boonstra VH, Mulder PG,et al. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.Clin Endocrinol 2003; 59(6): 779\u2013787.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"BF02760701_CR23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/archpedi.158.2.108","volume":"158","author":"I Cuttler","year":"2004","unstructured":"Cuttler I, Silver JB. Growth hormone treatment for idiopathic short stature implications for practice and policy.Arch Pediatr Adolesc Med 2004; 158(2): 108\u2013110.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BF02760701_CR24","volume-title":"Humatrope for Non-Growth Hormone Deficient Short Stature","author":"Endocrinologic and Metabolic Drugs Advisory Committee","year":"2003","unstructured":"Endocrinologic and Metabolic Drugs Advisory Committee. Humatrope for Non-Growth Hormone Deficient Short Stature. Indianapolis, Indiana: Lilly Research Laboratories, U.S.A.; 2003. Briefing Document."},{"issue":"2","key":"BF02760701_CR25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archpedi.156.3.230","volume":"156","author":"B Finkelstein","year":"2002","unstructured":"Finkelstein B, Imperiale T, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effects of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.Arch Pediatr Adolesc Med 2002; 156(2): 230\u2013240.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"BF02760701_CR26","doi-asserted-by":"crossref","unstructured":"Rosenfeld R, Hwa V. Toward a molecular basis for idiopathic short stature.J Clin Endocrinol Metab 89(3): 1066\u20131067.","DOI":"10.1210\/jc.2004-0092"},{"key":"BF02760701_CR27","doi-asserted-by":"crossref","unstructured":"Wit JM, Rekers-Mombarg LT. Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent.J Clin Endocrinol Metab 87(2): 604\u2013611.","DOI":"10.1210\/jcem.87.2.8225"},{"issue":"7","key":"BF02760701_CR28","first-page":"2969","volume":"86","author":"GA Kamp","year":"2001","unstructured":"Kamp GA, Mul D, Waelkens JJet al. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.Endocrinol Metab 2001; 86(7): 2969\u20132975.","journal-title":"Endocrinol Metab"},{"issue":"7","key":"BF02760701_CR29","first-page":"3061","volume":"86","author":"P Saenger","year":"2001","unstructured":"Saenger P, Wikland KA, Conway GSet al. Recommendations for the diagnosis and management of Turner syndrome.J Clin Endocrinol Metab 2001; 86(7): 3061\u20133069.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"BF02760701_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1542\/peds.111.3.692","volume":"111","author":"JL Frias","year":"2003","unstructured":"Frias JL, Davenport ML. Committee on Genetics and Section on Endocrinology. Health supervision for children with Turner syndrome.Pediatrics 2003; 111(3): 692\u2013702.","journal-title":"Pediatrics"},{"issue":"7","key":"BF02760701_CR31","first-page":"2439","volume":"85","author":"SD Chernausek","year":"2000","unstructured":"Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turner syndrome: the impact on final height Genetech, Inc., Collaborative Study Group.J Clin Endocrinol Metab 2000; 85(7): 2439\u20132445.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760701_CR32","doi-asserted-by":"crossref","unstructured":"Lee PDK, Allen DB, Angulo MAet al. Consensus statement\u2014 Prader-Willi Syndrome: growth hormone (GH)\/insulin-like growth factor axis deficiency and GH treatment.The Endocrinologist 10(4): 71\u201373.","DOI":"10.1097\/00019616-200010041-00015"},{"issue":"3","key":"BF02760701_CR33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1515\/JPEM.1996.9.3.393","volume":"9","author":"M Angulo","year":"1996","unstructured":"Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi Syndrome.J Pediatr Endocrinol Metab 1996; 9(3): 393\u2013400.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"BF02760701_CR34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/adc.78.5.474","volume":"78","author":"PS Davies","year":"1998","unstructured":"Davies PS, Evans S, Broomhead Set al. Effect of growth hormone on height, weight and body composition in Prader-Willi Syndrome.Arch Dis Child 1998; 78(5): 474\u2013476.","journal-title":"Arch Dis Child"},{"issue":"4","key":"BF02760701_CR35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1210\/jcem.87.4.8414","volume":"87","author":"AL Carrel","year":"2002","unstructured":"Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.J Clin Endocrinol Metab 2002; 87(4): 1581\u20131585.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"BF02760701_CR36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0031-3955(16)40098-2","volume":"42","author":"BA Warady","year":"2005","unstructured":"Warady BA, Jabs K. New hormones in the therapeutic arsenal of chronic renal failure: growth failure and erythropoietin.Pediatr Clin North Am 1995; 42(6): 1551\u20131577.","journal-title":"Pediatr Clin North Am"},{"issue":"15","key":"BF02760701_CR37","first-page":"805","volume":"6","author":"R Rosenfeld","year":"2000","unstructured":"Rosenfeld R, Allen DB, MacGillivray MH,et al. Growth hormone use in pediatric growth hormone deficiency and other pediatric growth disorders.Am J Managed Care 2000; 6(15): 805\u2013816.","journal-title":"Am J Managed Care"},{"key":"BF02760701_CR38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00019616-199805000-00007","volume":"8","author":"RN Fine","year":"1998","unstructured":"Fine RN. Growth hormone in children, with chronic renal insufficiency and end-stage renal disease.The Endocrinologist 1998; 8: 160\u2013169.","journal-title":"The Endocrinologist"},{"issue":"13","key":"BF02760701_CR39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"343","author":"D Haffner","year":"2000","unstructured":"Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.N Engl J Med 2000; 343(13): 923\u2013930.","journal-title":"N Engl J Med"},{"issue":"6","key":"BF02760701_CR40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1681\/ASN.V1261297","volume":"12","author":"V Roelfsema","year":"2001","unstructured":"Roelfsema V, Clark RG. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.J Am Soc Nephrol 2001; 12(6): 1297\u20131306.","journal-title":"J Am Soc Nephrol"},{"key":"BF02760701_CR41","doi-asserted-by":"crossref","unstructured":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.J Clin Endocrinol Metab 1998; 83 (2): 379\u2013381.","DOI":"10.1210\/jc.83.2.379"},{"issue":"1","key":"BF02760701_CR42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00006454-200301000-00017","volume":"22","author":"AM Rossum Van","year":"2003","unstructured":"Van Rossum AM, Gaakeer MI, Verweel Set al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type I infection treated with protease inhibitors.Pediatr Infect Dis J 2003; 22(1): 70\u201376.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"BF02760701_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpeds.2003.10.065","volume":"144","author":"MK Kamboj","year":"2004","unstructured":"Kamboj MK, Axelrod FB, David Ret al. Growth hormone treatment in children with familial dysautonomia.J Pediatr 2004; 144(1): 63\u201367.","journal-title":"J Pediatr"},{"issue":"11","key":"BF02760701_CR44","first-page":"4033","volume":"81","author":"M Shohat","year":"1996","unstructured":"Shohat M, Tick D, Barakat S, Bu X, Melmed S, Rimoin DL. Short term recombinant growth hormone treatment increases growth rate in achondroplasia.J Clin Endocrinol Metab 1996; 81(11): 4033\u20134037.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BF02760701_CR45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/adc.80.4.334","volume":"80","author":"G Anneren","year":"1999","unstructured":"Anneren G, Tuvemo T, Carlsson-Skwirut Cet al. Growth treatment in young children with Down's syndrome: effects on growth and psychomotor development.Arch Dis Child 1999; 80(4): 334\u2013338.","journal-title":"Arch Dis Child"},{"issue":"10","key":"BF02760701_CR46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1055\/s-2007-978949","volume":"30","author":"DS Hardin","year":"1998","unstructured":"Hardin DS, Stratton R, Kramer JC, de la Rocha RS, Govaerts K, Wilson DP. Growth hormone improves weight velocity and growth velocity in prepubertal children with cystic fibrosis.Horm Metab Res 1998; 30(10): 636\u2013641.","journal-title":"Horm Metab Res"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02760701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02760701\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02760701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:14:16Z","timestamp":1630552456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02760701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["BF02760701"],"URL":"https:\/\/doi.org\/10.1007\/bf02760701","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}